Sharing my results after 100 days of treatment. 1ml 5% minox x 2 a day, daily 1.25mg Finasteride , and weekly microneedling. 27M
    10/23/2025

    From the encyclopedia
    Minoxidil →

    Vasodilator used on the scalp and, at low doses, as a tablet

    Finasteride →

    Popular 5-alpha reductase inhibitor that lowers DHT, taken as a pill or used topically

    Microneedling →

    Technique that makes tiny punctures in the scalp with fine needles

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💧 Minoxidil (topical) 5% 2x daily 100 days
    💊 Finasteride (oral) 1.25mg daily 100 days
    💧 microneedling (topical) weekly 100 days
    the tone is 😀 positive with improvement over baseline results.

    Other terms

    A 27-year-old male shared his hair regrowth progress after 100 days using 5% Minoxidil twice daily, 1.25mg Finasteride daily, and weekly microneedling. He noticed improvements and hopes to avoid a future hair transplant.
    View this post in the Community →

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results

      research Functional hair follicle regeneration: an updated review

      42 citations , February 2021 in “Signal Transduction and Targeted Therapy”
      This review discusses potential cell sources and bioengineering strategies for regenerating hair follicles with functional cycling, reporting no new results.

      research Status of research on the development and regeneration of hair follicles

      November 2023 in “International Journal of Medical Sciences”
      This review examines the mechanisms of hair follicle development and regeneration, discussing current hair loss treatments and emerging therapies like low-level laser therapy and stem cell therapy, which the authors suggest show promise in managing hair loss.

      research Guidelines based management of androgenetic alopecia

      January 2014 in “Cosmoderma”
      This review examines the effectiveness of current treatments for androgenetic alopecia, offering plastic surgeons evidence-based guidance for choosing safe and effective options, but reports no new results.

      research Androgenetic alopecia: An update

      July 2023 in “JAAD International”
      This study describes androgenetic alopecia as a common non-scarring hair loss condition primarily influenced by genetic factors and androgen sensitivity, notably impacting psychosocial well-being, especially in females and younger males seeking treatment.